Correlation of HER2, p95HER2 and HER3 Expression and Treatment Outcome of Lapatinib plus Capecitabine in her2-Positive Metastatic Breast Cancer

• Sae-Won Han,

  Affiliations Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Yongjun Cha,

  Affiliation Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea

  ⨯
• Agnes Paquet,

  Affiliation Monogram Biosciences, Inc., San Francisco, California, United States of America

  ⨯
• Weidong Huang,

  Affiliation Monogram Biosciences, Inc., San Francisco, California, United States of America

  ⨯
• Jodi Weidler,

  Affiliation Monogram Biosciences, Inc., San Francisco, California, United States of America

  ⨯
• Yolanda Lie,

  Affiliation Monogram Biosciences, Inc., San Francisco, California, United States of America

  ⨯
• Thomas Sherwood,

  Affiliation Monogram Biosciences, Inc., San Francisco, California, United States of America

  ⨯
• Michael Bates,

  Affiliation Monogram Biosciences, Inc., San Francisco, California, United States of America

  ⨯
• Mojgan Haddad,

  Affiliation Monogram Biosciences, Inc., San Francisco, California, United States of America

  ⨯
• In Hae Park,

  Affiliation Center for Breast Cancer, National Cancer Center, Goyang, Korea

  ⨯
• Do-Youn Oh,

  Affiliations Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Keun Seok Lee,

  Affiliation Center for Breast Cancer, National Cancer Center, Goyang, Korea

  ⨯
• Seock-Ah Im,

  Affiliations Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Yung-Jue Bang,

  Affiliations Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

  ⨯
• Jungsil Ro ,

  * E-mail: kimty@snu.ac.kr (TYK); jungsro@ncc.re.kr (JR)

  Affiliation Center for Breast Cancer, National Cancer Center, Goyang, Korea

  ⨯
•  [ ... ],
• Tae-You Kim

  * E-mail: kimty@snu.ac.kr (TYK); jungsro@ncc.re.kr (JR)

  Affiliations Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea, Department of Molecular Medicine & Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Korea

  ⨯
• [ view all ]
• [ view less ]